Ligelizumab continues to trump Xolair in chronic spontaneous urticaria

9th January 2020 Uncategorised 0

The Novartis drug can bind to IgE with an 88-fold higher affinity than Xolair.

More: Ligelizumab continues to trump Xolair in chronic spontaneous urticaria
Source: News